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Background: Mechanisms of airway repair are poorly understood. It has been proposed that, following injury,
progenitor populations such as club cells (Clara) become undifferentiated, proliferate and re-differentiate to
re-epithelialise the airway. The exact phenotype of such cells during repair is unknown however. We hypothesised
that airway epithelial cells (AECs) undergo some degree of epithelial-mesenchymal transition (EMT) in order to
migrate over a denuded airway and effect re-epithelialisation. Furthermore, based on our previous findings that
BMP signalling is an early event in AECs following injury in vivo and that BMP4 down-regulates E-cadherin
expression and enhances migration in AECs in vitro, we hypothesised that BMPs could play a role in inducing such
a phenotypic switch.
Methods: Normal AECs were isolated from mouse lungs and analysed in a model of a disrupted epithelium. EMT
marker expression and BMP signalling were examined by immunofluorescence, Western blotting and RT-PCR.
Results: Following generation of a wound area, AECs at the wound edge migrated and acquired a mesenchymal-
like morphology. E-cadherin expression was reduced in migrating cells while vimentin and α-smooth muscle actin
(α-SMA) expression was increased. Re-expression of membrane E-cadherin was subsequently observed in some cells
in the wound area following re-establishment of the monolayer. A transient increase in the incidence of nuclear
phosphorylated Smad1/5/8 was observed in migrating cells compared with confluent cells, indicating active BMP
signalling during migration. BMP antagonists noggin and gremlin inhibited cell migration, confirming the
involvement of BMP signalling in migration and indicating autocrine signalling, possibly involving BMP7 or BMP4
which were expressed in AECs. Exogenous BMP2, BMP4 and BMP7 induced a mesenchymal-like morphology in
AECs, enhanced the rate of cell migration and increased α-SMA protein expression in AECs.
Conclusions: Following disruption of an intact epithelium, migrating AECs at the wound edge acquire an EMT-like
phenotype involving altered expression of E-cadherin, vimentin and α-SMA. BMP signalling is involved in AEC
migration and is likely to mediate the switch towards an EMT-like phenotype by altering protein expression to
facilitate cell migration and wound closure. We propose therefore that acquisition of an EMT-like phenotype by
AECs is a normal aspect of wound repair. Furthermore, we suggest that diseases involving fibrosis may arise
because the EMT phase of repair is prolonged by chronic injury/inflammation, rather than being caused by it, as is
the current paradigm.
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Several cell types including basal cells and submucosal
gland duct cells have been shown to function as
stem/progenitor cells in proximal murine airways [1].
In distal murine airways, the abundant club cell (Clara)
(previously known as the Clara cell) is believed to function
as a ‘facultative progenitor cell’ that can contribute to re-
epithelialisation of the airways after injury [2]. The club cell
has been described as being functional flexible, or ‘plastic’,
because it loses its characteristic differentiated phenotype
while it is renewing the injured epithelium and has been
described as ‘undifferentiated’ during this period. Subse-
quently, re-differentiation occurs and club cell functions
are restored. However, the precise phenotype of reparative
epithelial cells, such as club cells, while they are in the
process of actively repairing tissues has received little
attention to date. Such cells are poorly characterised in
any tissue type, including the airways. During epithelial
wound repair, surviving epithelial cells are required to
become migratory in order to re-epithelialise damaged
tissues. We have shown previously that an airway epithelial
cell migration phase precedes a proliferation phase in the
airway epithelium in vivo following acute lung injury
and that increased bone morphogenetic protein (BMP)
signalling is an early event during re-epithelialisation
[3]. However, wound repair processes in the airways, and
the signals that control them, remain poorly understood.
Myofibroblasts play a key role in tissue repair [4].
These are contractile cells and express α-smooth muscle
actin (α-SMA). During repair, myofibroblasts secrete a
temporary injury matrix of extracellular matrix (ECM)
components. Epithelial cells migrate over the injury
matrix and divide to replace damaged cells. During the
remodelling stage, myofibroblasts promote contraction
of the wound. While myofibroblasts play a key role in
both normal and abnormal wound repair in the lungs,
the source of these cells is unclear. It is thought that
local mesenchymal cells, bone marrow progenitor cells and
lung epithelial cells can all give rise to myofibroblasts, the
latter through EMT [5]. EMT occurs during development
and carcinogenesis and has been proposed as a contribu-
tory mechanism in fibrotic diseases [5]. During EMT,
epithelial cells lose many of their characteristic properties
and acquire features typical of mesenchymal cells. Protein
expression is altered to allow cells to become less tightly
attached to each other and more migratory. Transcriptional
downregulation of epithelial cell-cell adhesion molecules
occurs, and loss of E-cadherin in particular is considered a
hallmark of EMT. Typically, cytokeratin intermediate
filaments are replaced by vimentin and often α-SMA is
expressed. In addition to development, cancer and fibrosis,
an EMT-like process may occur during normal epithelial
wound healing although this concept has been mentioned
only sporadically in the literature [6].Transforming growth factor-β1 (TGF-β1) is considered
the prototype inducer of EMT and has been widely studied
in this capacity [7,8]. Bone morphogenic proteins (BMPs)
are highly conserved members of the TGF-β superfamily of
cytokines and are involved in a number of processes
throughout the body including morphogenesis, cell prolifer-
ation, differentiation, apoptosis and EMT [9]. BMP4 is an
important regulator of lung morphogenesis during develop-
ment and gremlin, a regulator of BMP signalling, negatively
regulates BMP4 during lung branching morphogenesis
[10,11]. However, few studies have addressed the role of
BMP signalling in adult lungs in health, regeneration or
disease. We have shown previously that increased bone
morphogenetic protein (BMP) signalling is an early event
in regenerating airway epithelial cells (AECs) in vivo
following acute injury [5]. We have also shown that BMP4
down-regulates E-cadherin and stimulates migration of
primary AECs in vitro indicating that BMP signalling may
play a role in epithelial cell migration during normal
wound healing in the airway epithelium.
Our group made the first report of an EMT process in
AECs when we demonstrated that BMP4 induces EMT
in human BEAS-2B cells [12]. Others have since shown
that TGF-β1 induces EMT in primary AECs and that
EMT may be enhanced in asthmatic airways [13,14].
Inflammation and elevated TGF-beta1 has been shown
to result in dysregulated airway epithelial repair and
fibrosis in a lung allograft via EMT [15]. Evidence of EMT
in AECs in fibrotic lungs during obliterative bronchiolitis
has also been reported [13]. However, EMT in pulmonary
fibrosis remains controversial [16]. In the present study, we
examined the phenotypic changes that airway epithelial
cells undergo during wound healing in order to deter-
mine whether an EMT-like process, rather than de-
differentiation per se, occurs. EMT has been reported
in a study of human skin wound healing, with a role dem-
onstrated for BMP2 [17]. This, along with our own data on
the effects of BMPs on lung cells, led us to hypothesise that
BMP ligands may be key regulators of this process. We
report that AECs undergo an EMT-like process during
wound repair, with downregulation of E-cadherin and
increased expression of α-SMA and vimentin, and that
BMP signalling plays a role in the process.
Methods
Primary AEC isolation
Ethical approval for this work involving animals was
granted by the Biological Sciences Research Ethics
Subcommittee, NUI Maynooth. Normal primary mouse
AECs were harvested from female C57BL/6 J mice as
described previously [18] with modifications described
in [19]. In brief, lungs were removed from euthanized
(sodium pentabarbitol overdose) mice, perfused with saline
and digested with trypsin. Lungs were then chopped and
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obtain clumps of airway epithelial cells. Because the
cells are isolated in clumps, cell counting using a
hemocytometer is not feasible. To ensure equal seeding
densities, an aliquot of cell isolate was taken before seeding
and an absorbance value (A450) was obtained using the
Cell Titer 96 AQueous One Solution Cell Proliferation
Assay (Promega Corp, Madison, Wisconsin, USA). Cell
suspensions were diluted appropriately based on A450
values to obtain equal seeding densities.Wound closure assay
The wound closure assay is a modification of the
Platypus Technologies Oris Cell Migration Assay (Platypus
Technologies, Abingdon, UK). Each well of an Oris 96-well
plate was prepared as follows: the centre area of the well
was coated with 50 ng/ml fibronectin, allowed to dry for
2 hr and a stopper was then placed in the well to cover
the fibronectin; the outer ring of the well was then
coated with 50 ng/ml collagen and incubated overnight
at 4°C; excess collagen was removed and primary mouse
AECs were seeded in serum-containing medium (SCM)
(1:1 Hams F12:M199 (Gibco, Glasgow, UK), 10% fetal
bovine serum, 2 mM L-glutamine (Gibco), 100 U/ml
penicillin and 100 μg/ml streptomycin (Gibco)) into
this outer area. After 2 days, SCM was replaced with
defined serum-free medium (SFM) (1:1 Hams F12:
M199 (Gibco), 2 mM l-glutamine, 100 U/ml penicillin,
100 μg/ml streptomycin, 100 U/ml insulin-transferin-
selenium (Gibco), 100 ng/ml hydrocortisone (Sigma-
Aldrich, Dublin, Ireland) and 10 ng/ml epidermal growth
factor (R&D Systems, Minneapolis, USA)). On day 5,
plugs were removed and medium was replaced with
fresh SCM. After 24 hr, cells were stained with 0.1%
crystal violet stain (Sigma-Aldrich). The Oris ‘detec-
tion mask’ was used to visualize the wound area with a
microscope. A photomicrograph of the entire wound
area taken and from this, the total number of migrated
cells in each wound was counted using Adobe Photoshop
CS3 Extended Cell Count software. To achieve full
epithelialisation of the wound area, plugs were re-
moved at day 3 and cells were allowed to grow for a
further 4 days in SCM.Treatment of AECs with BMP2, 4, 7, noggin and gremlin
Freshly isolated AECs were seeded onto Oris 96 well
migration plates (Nunc, Roskilde, Denmark) in SCM.
At day 2, medium was replaced with SFM. After 24 hr,
supernatant was removed and fresh SFM was added
containing appropriate concentrations of recombinant
BMP2, 4 and 7 (Immunotools, Germany; R&D Systems,
Minneapolis, USA) recombinant noggin (Peprotech, Rocky
Hill, NJ, USA) or recombinant gremlin (Sigma-Aldrich).Immunofluorescence
Cultured cells were fixed with pre-chilled methanol.
Tissue sections and cells were incubated with primary
antibodies overnight at 4°C followed by appropriate
Alexa FluorW 488-labeled secondary antibodies (Molecular
Probes, Invitrogen, Paisley, UK) for 30 min at room
temperature. Nuclei were counterstained with DAPI
(Sigma-Aldrich). Primary antibodies used were: α-SMA
(Sigma-Aldrich), p-Smad1/5/8, (Cell Signalling Technology),
E-cadherin (clone 36, BD Biosciences, Oxford, UK) and
vimentin (Sigma-Aldrich). Secondary antibody only controls
were carried out and representative images are shown in
Additional file 1: Figure S1.
RT-PCR
Semi quantitative RT-PCR for BMP2, BMP4 and BMP7
was carried out as described previously [6]. GAPDH was
used as the housekeeper control. Primer sets are shown
in Table 1.
Western blotting
Western blotting and densitometric analyses were car-
ried out as previously described [12]. Primary antibodies
used were: actin (clone 20–33, Sigma-Aldrich) and α-
SMA (Sigma-Aldrich).
Results
Induction of an EMT-like phenotype in AECs during
restitution of a disrupted epithelium
We have developed an in vitro model of wound healing
that allows evaluation of the dynamics of airway cell
morphology and migration during restoration of a
disrupted epithelium. With this model we have
attempted to recapitulate some of the key aspects of a
wounded airway epithelium in vivo. The area in the
centre of a well is coated with fibronectin, to represent a
wound matrix, and a plug is placed on top of this. The
remaining area encircling the plug is coated with
collagen, to represent a more normal matrix, and AECs
are seeded onto this area. The cells are cultured in
serum-containing medium (SCM) for 2 days to become
fully confluent and contact inhibited. To replicate the
low rate of cell proliferation in an uninjured airway epi-
thelium in vivo, the medium is replaced with serum-free
medium for 3 days to allow the cells to become as quies-
cent as possible. Following this, the confluent monolayer
is disrupted by removing the plug from the centre of the
well. The cells are then free to migrate onto the exposed
‘wound’ area and their ability to restore a confluent
monolayer is examined. A ‘mask’ which corresponds to
the confluent area can be placed on the well when view-
ing under a microscope to distinguish the confluent area
from the wound area (Figure 1A). We used this model
previously to demonstrate that BMP4 enhances the
Table 1 RT-PCR primer sets
Primer Sense Antisense
BMP2 5- CAGCATGTTTGGCCTGAAG −3 5- AAGTTCCTCCACGGCTTCTT-3
BMP4 5-CGTAGTCCCAAGCATCAC-3 5-ACAACATGGAAATGGCAC-3
BMP7 5- GGCTTCTCCTACCCCTACAA −3 5- GAACTCCCGATGGTGGTATC-3
GAPDH 5-CTGCACCACCAACTGCTTAG-3 5-CCAGGAAATGAGCTTGACAAA-3
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examine the phenotype of AECs during migration and
to further examine the role of BMP signalling in airway
epithelial wound healing. We have shown previously that
the method we use to isolate these murine AECs results in
cultures that contain >80% club cells with the remainder
comprising ciliated epithelial cells [19].
The epithelium was disrupted by removing a plug from
the centre of a well containing a confluent monolayer of
AECs. At 24 hr following plug removal, cells had
migrated past the wound edge (Figure 1B). TheseFigure 1 AECs migrate and acquire a mesenchymal-like morphology
no cells are observed in centre fibronectin-coated area where plug has bee
coated area. (b) At 24 hr, cells have migrated onto the ‘wound’ area. (c) Ce
confluent outer area. White dashed line indicates area previously occupied
plug. The plug was then removed at 0 hr to mimic wound generation. AEC
acquired a mesenchymal-like morphology while migrating into the woundmigrating cells had an elongated mesenchymal-like
morphology (Figure 1C). In contrast, cells in the confluent
outer areas of the well, distant from the wound edge,
retained a more regular epithelial-like morphology. In
order to exclude the possibility the migrating cells were
fibroblasts contaminating the epithelial cell preparation,
cytokeratin expression was analysed in samples of cells
prior to seeding and all cells were cytokeratin positive
(data not shown).
We examined expression of EMT-related markers in
migrating and confluent cells. Expression of the epithelialin disrupted epithelium model. A. AECs at 0 hr and 24 hr. (a) At 0 hr,
n removed. Black area shows detection mask covering collagen
lls stained with ethidium bromide/acridine orange to visualise the
by plug. B. AECs were allowed to become confluent around a central
migration into the wound area was evident at 24 hr. C. AECs
area.
McCormack et al. Respiratory Research 2013, 14:36 Page 5 of 12
http://respiratory-research.com/content/14/1/36marker E-cadherin was reduced and more cytoplasmic in
migrating AECs compared with confluent cells (Figure 2A).
In contrast, expression of the mesenchymal markers,
vimentin and α-SMA, was increased in migrating
AECs with cells displaying the characteristic filamentous
immunostaining pattern of these proteins (Figure 2B,C).
Confluent undisrupted AECs displayed low level diffuse
cytoplasmic immunostaining for both mesenchymal
proteins, presumably as a result of the culture process.
The monolayer was allowed to completely regenerate and
the expression of E-cadherin and α-SMA was examined at
day 4 post-plug removal, to determine if mesenchymal-
epithelial transition (MET) could occur. Most cells
remained α-SMA-positive at this stage (data not shown)
but colonies of E-cadherin-positive cells were evident
throughout the wound area (Figure 3). This suggests that
some cells are capable of undergoing MET following restor-
ation of cell-cell contacts. These primary AECs lose viability
at the stage of the culture so longer time points could not
be analysed to determine whether complete reversion to an
epithelial phenotype was possible.Figure 2 AECs acquire an EMT-like phenotype in wound repair mode
expression while E-cadherin expression was reduced in migrating AECs. In
C. α-SMA was increased in migrating AECs. ‘a’ and ‘b’ show higher magnifiBMP signalling during AEC wound healing
Given our previous findings that increased BMP signalling
is an early event in AECs following acute injury in vivo
[3], and that BMP4 down-regulates E-cadherin expression
and increases migration in AECs in vitro [3,12], we further
examined BMP signalling in the wound healing model.
During BMP signalling, BMP ligands bind to cell surface
BMP receptors. Activated receptors recruit and phosphor-
ylate receptor-regulated Smads (R-Smads) 1, 5 and/or 8.
Phosphorylated R-Smads form heteromeric complexes with
Smad4 and translocate to the nucleus where they act as
transcriptional co-modulators of specific target genes.
We first examined whether the wound healing model
reflected our observation of increased BMP signalling in
AECs following injury in vivo. Immunofluorescence for
phosphorylated Smad1/5/8 was performed on migrating
and confluent AECs cultured in serum-containing
medium at 1 hr, 24 hr and 48 hr following removal of
plugs from the centre of wells containing confluent
monolayers of AECs. Nuclear p-Smad1/5/8 was not
observed in confluent AECs (Figure 4A). However,l. A. Confluent areas of AECs retained E-cadherin membrane
contrast, expression of mesenchymal markers B. vimentin and
cation. Respective Dapi nuclear counterstain images are shown.
Figure 3 E-cadherin expression in AECs that have completed migration at day 4 post plug removal. A. Representative photomicrographs
show membrane E-cadherin expression in stationary cells at the cell border (white dashed line). Migrating cells do not express membrane
E-cadherin. White arrow indicated area where cells have re-expressed membrane E-cadherin. Respective DAPI nuclear counterstained images are
also shown. B. Higher power immunofluorescence images of membrane E-cadherin in non-migrating stationary MAECs at the cell border.
C. Higher power immunofluorescence images of re-established membrane E-cadherin expression following migration.
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AECs at 24 hr and this was reduced again to baseline
levels at 48 hr. This confirms that BMP signalling is
activated in migrating AECs similar to our findings in vivo.
Furthermore, it suggests that increased BMP signalling is a
transient event during epithelial regeneration.
In order to determine if BMP signalling is required for
AEC migration, BMP antagonists noggin and gremlin
were used to inhibit BMP signalling during wound
closure. Cells were cultured in serum-free medium prior
to removal of plugs from the centre of wells containing
confluent monolayers of AECs and noggin and gremlin
were subsequently added in serum-free medium. Noggin
induced a dose-responsive inhibition of the migration ofAECs (Figure 4B). After 48 hr, cell migration rate was
decreased 1.9-fold in the presence of 200 ng/ml noggin
compared to untreated control cells. In order to exclude
the possibility that noggin was reducing cell number
rather than inhibiting cell migration, MTS cell viability
assays were performed for all treatments at 24 hr and
48 hr and no significant difference between treatments
was detected (data not shown). A second BMP antagonist,
gremlin, also induced a dose-responsive reduction of AEC
migration. After 24 hours of gremlin treatment at 3 μg/ml,
cell migration rate decreased 1.9-fold compared to controls.
The inhibitory effects of noggin and gremlin indicate that
autocrine BMP signalling occurs during wound healing and
induces migration in AEC.
Figure 4 BMP signalling in AECs in wound repair model. A. Nuclear localised p-Smad1/5/8 was not evident in confluent AECs. In migrating
AECs, nuclear p-Smad1/5/8 was detected at 24 hr post-plug removal but was not seen at 48 hr. B. Noggin and gremlin induced a dose
responsive inhibition of AEC migration. Significance compared to control cells was obtained using the one-way ANOVA test (*P < 0.05), n = 3.
C. BMP4 and BMP7 mRNA expression was detected in confluent and migrating AECs. BMP2 expression was low in AECs. Image is representative
of 2 separate experiments.
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required for AEC migration, these results also importantly
indicate that autocrine BMP signalling in AECs plays a role
in cell migration, as the assays were carried out in serum-
free conditions in the absence of exogenous BMP ligands.
We therefore examined BMP ligand mRNA expression in
AECs. BMP2 is a homologue of BMP4 and both interact
with the same BMP receptors as BMP7. Expression of
BMP2, BMP4 and BMP7 mRNA was examined in migrat-
ing AECs at 2 hr, 6 hr, 24 hr and 48 hr post plug removal
and also in confluent undisrupted AECs. BMP4 and BMP7
were constitutively expressed in confluent cells over the
time course and no significant change in expression levels
were observed in migrating AECs (Figure 4C). In contrast,
BMP2 mRNA expression levels were low in confluent and
migrating AECs suggesting that this ligand is less likely to
be involved in autocrine signalling in AECs compared with
BMP4 and BMP7.
BMP2 and BMP7 induce an EMT-like response in airway
epithelial cells
Given our previous finding that the rate of AEC migration
in this wound healing model was increased in the presence
of 100 ng/ml BMP4 at 24 hr, we examined if BMP7
and BMP2 had similar effects on morphology and
migration of AECs.
Similar to our previous findings with BMP4, AECs
cultured in the presence of BMP7 or BMP2 displayed an
altered phenotype compared with control untreated cells.
In the absence of exogenous BMP7, cells appeared tightly
packed and had a regular, uniform morphology. In contrast,
following treatment with BMP7, cells adopted an elongated,
irregular shape and were more scattered (Figure 5A). A
similar effect was seen with BMP2.
A dose-responsive increase in the rate of migration of
AECs occurred in the presence of BMP7 over 24, 30 and
48 hr (Figure 5B,C). At 30 hr, migration rates were
increased 2.7- and 2.6-fold in response to 75 and
100 ng/ml BMP7 compared to untreated control cells.
After 48 hr, migration rates were increased 5.5-fold in
response to 100 ng/ml BMP7. No significant increase in
cell proliferation was detected (data not shown), indicating
that cell migration, rather than proliferation, was occurring
during this time. A dose-responsive increase in migration
of AECs exposed to increasing concentrations of BMP2
was also observed over 24, 30 and 48 hr, although the
extent of migration was slightly less compared with that
induced by BMP7. An MTS cell viability assay was carried
out with cells exposed to (100 ng/ml) BMP2 for 24 and
48 hr showed no significant increase in cell proliferation
during this period (results not shown). Therefore, all
three BMP ligands examined by us here and previously,
BMP4, -7 and −2, are capable of inducing a mesenchymal-
like morphology and increasing migration of AECs.BMP4, BMP7 and BMP2 increase expression of α-SMA in
AECs
We hypothesised that the increased expression of mesen-
chymal proteins in migrating AECs was also due to BMP
signalling. We therefore examined the effect of BMPs on
α-SMA expression in AECs. Cells cultured in the presence
of BMP4, -7 or −2 showed increased expression of α-SMA
in AECs by immunofluorescence and Western blotting
(Figure 6). Characteristic filamentous α-SMA immuno-
staining was evident in extensions of migrating cells.
Discussion
The process of airway regeneration after injury and
during disease remains poorly understood. In particular,
the mechanisms underlying re-epithelialisation are unclear.
In the field of airway stem and progenitor cell biology it is
generally thought that, in murine bronchiolar regions, club
cells function as a reparative cell population [6]. Following
injury, these cells are believed to become ‘un-differentiated’
after which they proliferate and re-differentiate in order to
re-epithelialise the airway wall. However, the precise
phenotype of these ‘un-differentiated’ cells has not been
characterised. Our data suggests that in fact, instead of
being un-differentiated, these reparative cells temporarily
acquire an EMT-like phenotype in order to carry out re-
epithelialisation. This remains consistent with the reported
loss of epithelial-related protein expression in these cells.
We suggest that following re-epithelialisation of the
damaged area, a mesenchymal-epithelial transition (MET)
occurs to restore the differentiated epithelium.
In addition, we propose that BMPs play a key role in
this wound-related EMT process, mirroring the important
role of these proteins in lung development [20]. Several
studies have identified a correlation between BMP signal-
ling and EMT during embryonic development, fibrosis and
cancer [21-23]. We now show that BMP induced EMT
may also occur in airway regeneration processes. BMP2,
BMP4 and BMP7 are important morphogens and are
critical to a variety of developmental processes. BMP2 and
BMP4 are 92% identical. Homozygous deletions of BMP2
and BMP4 in mice result in embryonic lethality involving
abnormal heart development and a failure of mesoderm
formation respectively, both involving EMT [24]. BMP7
also plays a key role in development [25]. While specific
roles for BMP2 and BMP7 in lung development have not
yet been described, BMP4 regulates airway branching and
influences proximal-to-distal differentiation of airway epi-
thelial cells in developing lungs [26]. Gremlin is expressed
in pulmonary endothelial cells and has been shown to block
BMP-stimulated wound healing in these cells [27]. The
roles of these signalling molecules in adult lungs have not
been widely studied however. We hypothesised that BMPs
2, 4 and 7 may play key roles in directing lung repair and
regeneration after injury and we reported previously that
Figure 5 BMP4, BMP7 and BMP2 induce a mesenchymal-like morphology and migration in AECs. A. AECs cultured in the presence of
BMP4, BMP7 and BMP2 acquired an irregular shape and were more scattered compared with untreated cells, magnification x20. B. Increased
numbers of AECs were evident in the wound area at 48 hr in the presence of 100 ng/ml BMP4, BMP7 and BMP2, magnification x4. C. BMP4,
BMP7 and BMP2 increased the rate of cells migration in a dose dependent manner. Significance compared to control cells was obtained using
the one-way ANOVA test (*P < 0.05), n = 3.
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epithelial cells following acute lung injury [3]. We have also
previously show that BMP4 induces morphological and
phenotypic changes in AECs similar to EMT, including
down regulation of E-cadherin, and that cell migration is
also increased by BMP4 [3,12].
In the present study, we aimed to utilise an epithelial
restoration assay to investigate specific aspects of BMPsignalling in AECs during regeneration. The demonstration
of nuclear localisation of p-Smad1/5/8 in migrating AECs
in vitro here concurs with our previous finding of increased
nuclear p-Smad1/5/8 in AECs in vivo in the early stages of
regeneration after acute lung injury [3]. This activation of
BMP signalling pathways was early and transient, both in
our previous in vivo study and in the present study. We
believe that BMP signalling is a key early event in
Figure 6 BMPs increase expression of α-SMA in AECs. A. Low levels of α-SMA were detected by immunofluorescence in control AECs that
were not treated with exogenous BMPs. Increased levels of α-SMA were observed in cells cultured with BMP7, BMP2 or BMP4 compared with
controls. Arrows show migrating cells with membranes extensions that contain characteristic α-SMA fibres. B. Densitometric analysis of Western
blots also demonstrated that α-SMA levels were elevated in AECs cultured with BMP7, BMP2 or BMP4. Significance compared to control cells was
obtained using the one-way ANOVA test (*P < 0.05), n = 3.
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pathway can regulate itself by negative feedback control by
directly transcriptionally upregulating inhibitor Smads 6
and 7 [28]. Chronic injury may overwhelm this negative
feedback, leading to sustained Smad signalling and
resulting in a more permanent EMTand ultimately fibrosis.
In our studies, control wells with serum containing
media showed enhanced cell migration compared with
BMP ligands. Clearly factors such as fibroblast growth
factors, FGF, TGF-β1 and possibly additional BMP
ligands are likely to be present in serum and play a role
in cell migration also.
A small number of other studies have examined BMP
signalling pathway components in lung tissue. Smad
activation has been reported in AECs during allergic
inflammation [29,30]. However, the source of BMP ligands
in the lungs, and the role of BMP-mediated signalling in
AECs, has been unknown. We now demonstrate that
autocrine BMP signalling occurs in AECs, possibly via
BMP4 and BMP7 which we show are expressed in these
cells, and that a function of this signalling is the enhance-
ment of cell migration. Interestingly, levels of BMP2
mRNA were low, suggesting differential roles for BMP2
and BMP4 in AECs. We have also demonstrated that
exogenous BMP2, BMP4 and BMP7 are capable of enhan-
cing migration of AECs. Therefore, we can postulate thatduring airway regeneration in vivo, the source of BMP4
and BMP7 ligands is likely to include AECs themselves
while other cell types are likely to be the source of BMP2.
It has recently been reported that BMP2 is expressed in
smooth muscle and vascular endothelial cells of blood
vessels in vascular and skeletal tissues, but not by lymph-
atic vessels or macrophages [31]. Muscle and endothelial
cells may also be sources of BMP2 in the lungs. Reports of
the role of BMP7 in adult epithelial tissues have been
somewhat contradictory. BMP7 has been reported to
reverse TGF-β1-induced fibrotic effects in vitro in organs
such as the heart, colon and kidneys [32]. In contrast,
BMP7 does not reverse TGF-β1-induced EMT in human
renal epithelial cells [33] and no inhibitory effect was
observed in bleomycin-induced lung or skin fibrosis
models [32,34]. Our data suggest that BMP7 promotes an
EMT-like response in AECs.
In some circumstances, the wound repair process can
become disregulated. During situations of chronic in-
flammation or recurrent injury, excess accumulation of
ECM components at the site of injury can lead to
permanently remodelled tissue. While myofibroblasts
play a key role in both normal and abnormal wound
repair in the lungs, the source of these cells is unclear. It
is thought that local mesenchymal cells, bone marrow
progenitor cells and lung epithelial cells can all give rise
McCormack et al. Respiratory Research 2013, 14:36 Page 11 of 12
http://respiratory-research.com/content/14/1/36to myofibroblasts, the latter through EMT [4]. However,
the extent to which each of these three cell populations
contributes to myofibroblast recruitment, and whether
these contributions differ in normal versus abnormal
repair is unknown. Our data suggests that repairing
AECs may be a source of these myofibroblasts. Further-
more we suggest that a paradigm in the fibrosis field
could be adjusted also. It has been proposed that severe/
chronic injury and/or inflammation in the airways and
other tissues causes epithelial cells to undergo EMT that
contributes to fibrosis [35,36]. Instead, we speculate that
chronic/severe injury or inflammation may not directly
induce EMT in epithelial cells to cause fibrosis. Rather,
EMT occurs as a normal repair process during the initial
injury but fails to reverse via MET because of the
chronic injury conditions, leading to a permanent EMT
that results in airway fibrosis. This is consistent with the
view of fibrosis as a permanent injury state, but with the
difference that the initial EMT event is a normal injury
response. The problem may arise when the subsequent
MET is delayed or inhibited by persistent injury/inflamma-
tion. If this is correct, strategies to treat fibrosis could
address encouragement of MET. Further studies are re-
quired to fully characterise the extent to which EMT occurs
in AECs during wound healing and to determine whether
MET occurs once re-epithelialisation is complete.
Conclusions
During wound repair, AECs acquire an EMT-like pheno-
type involving altered expression of E-cadherin, vimentin
and α-SMA. BMP signalling is involved in AEC migration
and is likely to mediate the switch towards an EMT-like
phenotype by altering protein expression to facilitate
cell migration and wound closure. We propose there-
fore that acquisition of an EMT-like phenotype by
AECs is a normal aspect of wound repair. Furthermore,
we suggest that diseases involving fibrosis may arise
because the EMT phase of repair is prolonged by
chronic injury/inflammation, rather than being caused
by it, as is the current paradigm. In summary, this
study indicates that regenerating AECs acquire an
EMT-like phenotype during wound repair and that
BMPs play a key role in regulating this process.Additional file
Additional file 1: Figure S1. Immunofluorescence images of secondary
antibody controls. Antibodies are conjugated with Alexa 488 fluorophore.
Images are shown for anti-mouse, anti-goat and anti-rabbit secondary
antibodies. DAPI counter stain is also shown.
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